-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
[Pharmaceutical Network Industry News] According to the 2021 Annual Monitoring Circular of the Provincial Pharmaceutical Recruitment and Procurement Price Guidance Mechanism issued by the Hainan Provincial Medical Insurance Bureau on March 17, 5,049 varieties of drugs were received by enterprises to reduce their prices, with an average decrease of 31.
82%.
, a high drop of 98.
93%, and some drugs dropped more than expected
.
In January 2021, the province's pharmaceutical procurement price guidance mechanism was officially launched.
The establishment of this guidance mechanism is mainly to improve the market-led pharmaceutical price formation mechanism, improve the supervision level in the field of pharmaceutical purchase and sales, and guide pharmaceutical prices to return to a reasonable space.
There is also a pharmaceutical procurement price monitoring system that matches the construction of the free trade port, which aims to solve the problems of lack of policies and low efficiency in the field of pharmaceutical procurement price monitoring in the province, and to introduce new methods for follow-up research.
It has laid a solid foundation for the policy of recruiting, purchasing and hanging on the Internet and the management policy of purchasing and distribution
.
The circular shows that in 2021, the guidance mechanism will capture a total of 252,600 pieces of national drug price information, and receive 9,976 pieces of information on disposal by enterprises and medical institutions, with an acceptance rate of 80.
6%
.
Early warning information includes seven types of early warnings, including early warning of qualification validity period, early warning of national lowest price monitoring and early warning when hanging on the Internet, early warning of abnormal price changes of medicines, early warning of monitoring and early warning of untimely delivery, early monitoring and early warning of untimely receipt of goods, monitoring and early warning of shortage of medicines, and early warning of risk of sales with gold.
.
Throughout the year, a total of over 499 medical institutions, 3,617 production enterprises and 223 distribution enterprises have been evaluated for points and credit.
The overall monitoring has achieved remarkable results, which are mainly reflected in four aspects
.
Among them, in terms of reducing the drug burden of the people in the province, after the early warning, 5,049 varieties of drugs were received by enterprises to reduce their prices in the whole year, with an average decline of 31.
82%, and the highest decline was 98.
93%.
Some drugs fell more than expected.
Liplatin injection decreased from 1280 yuan/bottle to 298 yuan/bottle, a decrease of 76.
71%
.
According to the comparison of the purchase amount before and after the price reduction, it is estimated that the total saving of purchase funds for the whole year is 113 million yuan (excluding centralized purchase and state-negotiated drugs)
.
In addition to companies taking the initiative to reduce drug prices, the purchase of high-priced drugs by medical institutions has also been effectively restrained, further curbing the trend of corruption in medical institutions
.
Through clear monitoring indicators to guide the return of purchase prices, 207 red lights and 26,778 yellow light warnings were sent to medical institutions throughout the year.
Relying on this monitoring method, medical insurance departments at all levels guide medical institutions to comprehensively measure the price of purchased medicines and proactively purchase low-priced medicines The number of medical institutions has greatly increased
.
In addition, for pharmaceutical companies, the industry regulation they face is becoming more and more strict
.
Throughout the year, 9,200 pieces of online price warning information were sent to pharmaceutical companies.
Combined with the guidance of points assessment, the proportion of pharmaceutical companies with a score lower than 60 dropped to 36.
72%; companies and medical institutions are required to conduct self-inspection and rectification in a timely manner, and match disciplinary measures.
694 medicines and 5132 medical consumables were withdrawn from the net
.
Since the operation of the mechanism, the timely payment rate of the province's centralized procurement of medicines and consumables has reached more than 90%, and the business environment has been continuously optimized
.
It is reported that in the next step, the province will also improve the application level of the results
.
Focus on improving the internal notification and punishment mechanism, focus on reporting a group of cities and counties, medical institutions and pharmaceutical companies in the lower ranks, push a batch of problem monitoring information to the industry competent authorities in a timely manner, carry out a batch of pharmaceutical enterprise credit ratings in a timely manner, and monitor The results are used in follow-up bidding procurement, contract renewal of selected results of centralized pharmaceutical procurement, agreement assessment of designated medical institutions, and balance retention assessment to ensure the efficient transformation of monitoring results
.
At the same time, it will also provide decision support capabilities, assist in the construction of demonstration projects, and improve the functions of monitoring modules
.
Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyone
.
82%.
, a high drop of 98.
93%, and some drugs dropped more than expected
.
In January 2021, the province's pharmaceutical procurement price guidance mechanism was officially launched.
The establishment of this guidance mechanism is mainly to improve the market-led pharmaceutical price formation mechanism, improve the supervision level in the field of pharmaceutical purchase and sales, and guide pharmaceutical prices to return to a reasonable space.
There is also a pharmaceutical procurement price monitoring system that matches the construction of the free trade port, which aims to solve the problems of lack of policies and low efficiency in the field of pharmaceutical procurement price monitoring in the province, and to introduce new methods for follow-up research.
It has laid a solid foundation for the policy of recruiting, purchasing and hanging on the Internet and the management policy of purchasing and distribution
.
The circular shows that in 2021, the guidance mechanism will capture a total of 252,600 pieces of national drug price information, and receive 9,976 pieces of information on disposal by enterprises and medical institutions, with an acceptance rate of 80.
6%
.
Early warning information includes seven types of early warnings, including early warning of qualification validity period, early warning of national lowest price monitoring and early warning when hanging on the Internet, early warning of abnormal price changes of medicines, early warning of monitoring and early warning of untimely delivery, early monitoring and early warning of untimely receipt of goods, monitoring and early warning of shortage of medicines, and early warning of risk of sales with gold.
.
Throughout the year, a total of over 499 medical institutions, 3,617 production enterprises and 223 distribution enterprises have been evaluated for points and credit.
The overall monitoring has achieved remarkable results, which are mainly reflected in four aspects
.
Among them, in terms of reducing the drug burden of the people in the province, after the early warning, 5,049 varieties of drugs were received by enterprises to reduce their prices in the whole year, with an average decline of 31.
82%, and the highest decline was 98.
93%.
Some drugs fell more than expected.
Liplatin injection decreased from 1280 yuan/bottle to 298 yuan/bottle, a decrease of 76.
71%
.
According to the comparison of the purchase amount before and after the price reduction, it is estimated that the total saving of purchase funds for the whole year is 113 million yuan (excluding centralized purchase and state-negotiated drugs)
.
In addition to companies taking the initiative to reduce drug prices, the purchase of high-priced drugs by medical institutions has also been effectively restrained, further curbing the trend of corruption in medical institutions
.
Through clear monitoring indicators to guide the return of purchase prices, 207 red lights and 26,778 yellow light warnings were sent to medical institutions throughout the year.
Relying on this monitoring method, medical insurance departments at all levels guide medical institutions to comprehensively measure the price of purchased medicines and proactively purchase low-priced medicines The number of medical institutions has greatly increased
.
In addition, for pharmaceutical companies, the industry regulation they face is becoming more and more strict
.
Throughout the year, 9,200 pieces of online price warning information were sent to pharmaceutical companies.
Combined with the guidance of points assessment, the proportion of pharmaceutical companies with a score lower than 60 dropped to 36.
72%; companies and medical institutions are required to conduct self-inspection and rectification in a timely manner, and match disciplinary measures.
694 medicines and 5132 medical consumables were withdrawn from the net
.
Since the operation of the mechanism, the timely payment rate of the province's centralized procurement of medicines and consumables has reached more than 90%, and the business environment has been continuously optimized
.
It is reported that in the next step, the province will also improve the application level of the results
.
Focus on improving the internal notification and punishment mechanism, focus on reporting a group of cities and counties, medical institutions and pharmaceutical companies in the lower ranks, push a batch of problem monitoring information to the industry competent authorities in a timely manner, carry out a batch of pharmaceutical enterprise credit ratings in a timely manner, and monitor The results are used in follow-up bidding procurement, contract renewal of selected results of centralized pharmaceutical procurement, agreement assessment of designated medical institutions, and balance retention assessment to ensure the efficient transformation of monitoring results
.
At the same time, it will also provide decision support capabilities, assist in the construction of demonstration projects, and improve the functions of monitoring modules
.
Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyone
.
